About our organisation
Explore our vision, mission, members and more
A pan-European collaborative research network for vaccine monitoring
Our mission is to deliver timely and robust real-world evidence on vaccines and cutting-edge methodology through a European community of expert organisations. As the sustainability solution for IMI-funded project ADVANCE, we are implementing their vision of enabling evidence-based decision-making on vaccines. We employ a streamlined governance structure including four bodies representing our members and maintain strategic and fruitful collaborations with like-minded organisations
Research
Explore our study methodologies and data sources
A shared framework and tools for the conduct of RWE studies
VAC4EU has developed a streamlined study pipeline for the generation of RWE from RWD. This standardised pipeline forms the basis for the work carried out by study teams, informing on vaccine safety and effectiveness across Europe. The network consists of 14 data sources based across Europe which provide a range of different types of data for RWE studies. To support members in both the RWD to RWE pipeline and more generally in the development and execution of RWE studies, a bespoke selection of methods and tools are available to VAC4EU members and regularly updated by a team of experts.
Impact
Explore what we have achieved as a network
The VAC4EU network strives for better vaccine safety and effectiveness research across Europe. This common goal unites members to produce high quality outputs which have the capacity to influence the RWE landscape across Europe and beyond. VAC4EU has had tangible impact through the publication of a number of peer-reviewed manuscripts and public deliverables, presentations at major pharmacoepidemiology and vaccine conferences including ISPE and WVC as well as the establishment of a study portfolio covering post-authorisation safety monitoring of recent vaccines for SARS-Cov-2 and RSV.